{
  "documentMetadata": {
    "title": "Syphilis, Secondary",
    "sourceFile": "syndromes/genitourinary/syphilis/Syphilis, Secondary.pdf",
    "lastUpdated": "2023-05-08"
  },
  "content": [
    {
      "type": "header",
      "level": 2,
      "text": "Clinical Setting"
    },
    {
      "type": "list",
      "items": [
        "Fever, papulosquamous rash often involving palms of hands and soles of feet, aseptic meningitis.",
        "References: JAMA 312:1905, 2014; Clin Infect Dis 2015 61:S818.; Lancet 2017 389:1550 and N Engl J Med. 2020;382:845"
      ]
    },
    {
      "type": "header",
      "level": 2,
      "text": "Etiologies"
    },
    {
      "type": "list",
      "items": [
        "Treponema pallidum"
      ]
    },
    {
      "type": "header",
      "level": 2,
      "text": "Primary Regimens"
    },
    {
      "type": "drugRegimen",
      "regimenData": {
        "intent": "treatment",
        "components": [
          {
            "drug": "Benzathine Penicillin G (Bicillin L-A)",
            "dose": "2.4 million units",
            "route": "IM",
            "frequency": "x 1 dose"
          }
        ]
      }
    },
    {
      "type": "header",
      "level": 2,
      "text": "Alternative Regimens"
    },
    {
      "type": "drugRegimen",
      "regimenData": {
        "intent": "treatment",
        "components": [
          {
            "drug": "Doxycycline",
            "dose": "100 mg",
            "route": "po",
            "frequency": "bid",
            "connector": "or"
          },
          {
            "drug": "Tetracycline",
            "dose": "500 mg",
            "route": "po",
            "frequency": "qid"
          }
        ],
        "durationDetail": {
          "fixedDuration": "14 days"
        }
      }
    },
    {
      "type": "drugRegimen",
      "regimenData": {
        "intent": "treatment",
        "components": [
          {
            "drug": "Ceftriaxone",
            "dose": "1 gm",
            "route": "IM/IV",
            "frequency": "q24h"
          }
        ],
        "durationDetail": {
          "fixedDuration": "10-14 days"
        },
        "notes": "though exact duration and dose unclear"
      }
    },
    {
      "type": "list",
      "items": [
        "European 2020 Syphilis Guidelines recommend Procaine Penicillin 600,000 units IM daily for 10â€“14 days, if benzathine Penicillin G not available.",
        "Azithromycin 2 gm po single dose no longer recommended due to increasing resistance.",
        "Follow-up is mandatory.",
        "Pregnancy: all should be treated with Penicillin; If penicillin-allergic, the patient should be desensitized. See Methods for Penicillin Desensitization."
      ]
    },
    {
      "type": "paragraph",
      "text": "In some countries, benzathine Penicillin G is not available and shortages are increasingly common."
    },
    {
      "type": "list",
      "items": [
        "Consider high dose Amoxicillin 3 gm/day with probenecid (750 mg/day) po given tid in divided doses x 2 weeks (early syphilis) x 4 weeks (late latent or unknown duration) based on Japanese experience in HIV-infected individuals (efficacy 95.5%, 273/286 patients; Clin Infect Dis 61:177, 2015).",
        "Another alternative is Amoxicillin 1.5 g/day is better tolerated than above Amoxicillin/Probenicid combination with similar efficacy (94.9%) Sex Transm Infect 98:173 2022"
      ]
    },
    {
      "type": "header",
      "level": 2,
      "text": "Comments"
    },
    {
      "type": "list",
      "items": [
        "Test all patients with syphilis for HIV and all HIV patients for syphilis.",
        "Perform quantitative nontreptonemal test (VDRL or RPR) at 0, 3, 6, 12 and 24 months after treatment.",
        "If primary or secondary syphilis, VDRL should decrease 2 tubes (i.e. 4 fold) at 6 months, 3 tubes at 12 months and 4 tubes in 24 months.",
        "Current 2021 CDC recommendations no longer recommend to examine CSF if titers fail to fall 4-fold, rather to follow titers and neurological exam.",
        "Secondary syphilis as the great imitator: e.g., cervical lymphadenitis Clin Infect Dis 58: 1577, 2014.",
        "Reviews: 2021 CDC STD guidelines MMWR Recomm Rep 70 (RR-4):1 2021; European 2020 Syphilis Guidelines and N Engl J Med. 2020;382:845",
        "Review of evidence for CDC guidelines: Clin Infect Dis 74:S127 2022"
      ]
    }
  ]
}
